We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

108 hedge funds and large institutions have $355M invested in Lifecore Biomedical in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

9% more funds holding

Funds holding: 99 → 108 (+9)

4% more capital invested

Capital invested by funds: $342M → $355M (+$13.8M)

17% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 36

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
108
Holders Change
+9
Holders Change %
+9.09%
% of All Funds
2.91%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
15
Increased
30
Reduced
36
Closed
6
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
-$229K

Top Buyers

Rank Fund Capital Flow
1
HA
Heartland Advisors
Wisconsin
+$6.21M
2
SFM
Systematic Financial Management
New Jersey
+$3.14M
3
RFC
Russell Frank Company
Washington
+$2.91M
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$2.55M
5
TAM
THB Asset Management
Connecticut
+$1.86M

Top Sellers

Rank Fund Capital Flow
1
GC
Guggenheim Capital
Illinois
-$8.86M
2
OCG
Opus Capital Group
Ohio
-$5.38M
3
AI
Ariel Investments
Illinois
-$4.92M
4
Morgan Stanley
Morgan Stanley
New York
-$2.39M
5
KG
Killen Group
Pennsylvania
-$971K
Name Holding Trade Value Shares
Change 		Change in
Stake
GIM
26
Granahan Investment Management
Massachusetts
$3.11M -$802K -55,600 -21%
JGUA
27
John G. Ullman & Associates
New York
$2.84M -$297K -20,550 -9%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.75M +$22.2K +1,541 +0.8%
SCM
29
Summit Capital Management
Washington
$2.65M -$243K -16,865 -8%
Arrowstreet Capital
30
Arrowstreet Capital
Massachusetts
$2.64M -$53.9K -3,738 -2%
NSIM
31
North Star Investment Management
Illinois
$2.56M – – –
Ohio Public Employees Retirement System (OPERS)
32
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.48M – – –
Geode Capital Management
33
Geode Capital Management
Massachusetts
$2.45M +$166K +11,536 +7%
TAM
34
THB Asset Management
Connecticut
$1.86M +$1.86M +129,210 New
GIP
35
Granite Investment Partners
California
$1.61M -$412K -28,554 -20%
BIM
36
BlackRock Investment Management
Delaware
$1.48M +$200K +13,872 +16%
TBAM
37
True Bearing Asset Management
California
$1.34M -$853K -59,073 -39%
TCIM
38
TIAA CREF Investment Management
New York
$1.31M -$257K -17,794 -16%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$1.29M -$50.5K -3,500 -4%
MAA
40
Managed Account Advisors
New Jersey
$1.27M -$333K -23,099 -21%
Charles Schwab
41
Charles Schwab
California
$1.19M +$32K +2,214 +3%
AA
42
Ancora Advisors
Ohio
$1.11M +$1.11M +77,176 New
BCM
43
Buckhead Capital Management
Georgia
$1.08M – – –
USAA
44
United Services Automobile Association
Texas
$1.04M – – –
TC
45
TFS Capital
Pennsylvania
$1.02M +$1.02M +71,002 New
BCM
46
Bridgeway Capital Management
Texas
$999K -$289K -20,000 -22%
AssetMark Inc
47
AssetMark Inc
California
$954K -$40.8K -2,828 -4%
Asset Management One
48
Asset Management One
Japan
$784K – – –
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$710K +$4.82K +334 +0.7%
WCM
50
Wedge Capital Management
North Carolina
$704K – – –
1
2
3 4 5

LFCR Hedge Fund Activity: Q2 2015 in Review

108 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q2 2015, worth a combined $355M — up 4% from $342M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new LFCR positions and 6 closed out — a net gain of 9 holders — while 30 added to existing stakes and 36 trimmed.

The largest buyer was Heartland Advisors, adding an estimated $6.21M. The largest seller was Guggenheim Capital, cutting an estimated $8.86M.

  • 108 institutional investors held Lifecore Biomedical (LFCR) as of Q2 2015, up from 99 in Q1 2015.
  • Funds reported $355M of Lifecore Biomedical stock for Q2 2015, up 4% quarter-over-quarter.
  • 15 funds opened new Lifecore Biomedical positions in Q2 2015 and 6 closed out, a net change of +9 holders.
  • The largest Lifecore Biomedical buyer in Q2 2015 was Heartland Advisors, an estimated $6.21M added.
  • The largest Lifecore Biomedical seller in Q2 2015 was Guggenheim Capital, an estimated $8.86M sold.

Based on aggregated 13F filings for Q2 2015.